# Beaverbio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beaverbio

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.beaverbio.com
- Latest round: Series B (Apr 21, 2021)
- Investors on record: 5

## About

Based in Suzhou, China and established in 2011, Beaverbio is a biological materials developer which focuses on Nano magnetic bead technology. The technology has developed from the first generation of dispersion structure Nano magnetic beads technology, the second generation of core-shell structure silica beads, to the third generation of multi-sandwich structure polymer magnetic beads. The company has hired experts in material science Dr. Mingxian Huang as Chief Science Officer. The company has build up more than 6000 square meter for industry base. The company has raised series B funding recently. The company provides Nano magnetic bead materials, protein coupling intermediate, immune magnetic beads, high pure viral RNA kit, auxiliary biological consumables and other equipment for biology research, in vitro diagnosis and genetic testing. The company is establishing 3000 square meter for research center and the funding will be utilized for the mass production in the third generation of multi-sandwich structure polymer magnetic beads and technology research for the fourth generation Nano magnetic beads.

## Funding rounds

- Series B, Apr 21, 2021 — CM Venture Capital, Clivia Capital, Huihe Capital
- Series A, May 31, 2017 — Watson Capital, BICI Capital Fortune

## Investors

- Watson Capital (https://capitalatlas.ai/funds/watson-capital) — Series A
- BICI Capital Fortune (https://capitalatlas.ai/funds/bici-capital-fortune) — Series A
- CM Venture Capital (https://capitalatlas.ai/funds/cm-venture-capital) — Series B
- Clivia Capital — Series B
- Huihe Capital — Series B